Optimized density and locations of stroke centers for improved cost effectiveness of mechanical thrombectomy in patients with acute ischemic stroke.

Authors:
Ennab Vogel N; Wester P; Andersson Granberg T; Levin LÅ.

Journal:
J Neurointerv Surg

Publication Year: 2024

DOI:
10.1136/jnis-2023-020299

PMCID:
PMC10850679

PMID:
37072170

Journal Information

Journal Title: J Neurointerv Surg

Detailed journal information not available.

Publication Details

Subject Category: Neuroimaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"moreover the model allows hospitals to overutilize staffing resources by 25% before prompting the installment of additional staffing resources required for performing 150 mt procedures per year ( figure 1b ) 10 1136/jnis-2023-020299 supp1 supplementary data 10 1136/jnis-2023-020299 supp3 supplementary data the patient level cost items consisted of individually estimated ems patient transportation costs staffing and equipment costs associated with different treatment modalities (cvt ivt and/or mt) and mrs categorized first and second year costs post-stroke derived from the literature and takes on a societal perspective ( table 1 )."

Code Sharing
Evidence found in paper:

"Competing interests: NEV reports academic grants from Linköping University. PW reports academic grants from University of Umeå and the Swedish Heart and Lung foundation. He has research contracts with Abbott and Bristol Myers Squibb. L-ÅL has research contracts with Bayer, Boehringer Ingelheim, AstraZeneca, and Janssen. He has been on advisory boards for Bayer, Boehringer Ingelheim, Pfizer, BMS, MSD, and GSK."

Evidence found in paper:

"Funding: This study was supported by the Center for Advanced Research in Emergency Response (CARER) at Linköping University, Sweden, and Region Östergötland, Sweden."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025